How difficult was it to get a patent for the anti-impotency drug, Sildenafil Citrate?
We did not get a patent for the drug. We only got permission to export. Of course, we follow a different process, different from Pfizer, so we sought permission from the government to manufacture and export. So, you would export without any brand name. That’s right. Which countries are you going to export? The demand is there all over the world. But we can only export to the countries where Pfizer is not selling under their brand name Viagra. At present, only Pfizer is selling the drug under a brand name. But there are many countries where Pfizer does not have the patent. Last week, you were in Kuwait. Has your visit anything to do with the drug? No, my Kuwait visit has nothing to do with this drug. We earn our bread and butter from other products like Cephalosporin antibiotics, which we manufacture in our Madras factory. Yes, we have a very good market in the Middle East. But we are getting inquiries for this anti-impotency drug from all over the world. We’ll be selling to the Far Eas
